Acquired factor V deficiency following transcatheter arterial chemoembolization for hepatocellular carcinoma: a case report

Ortel TL (1999) Clinical and laboratory manifestations of anti-factor V antibodies. J Lab Clin Med 133:326–334

Tracy PB, Eide LL, Bowie EJ et al (1982) Radioimmunoassay of factor V in human plasma and platelets. Blood 60:59–63

Streiff MB, Ness PM (2002) Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure. Transfusion 42:18–26

Knobl P, Lechner K (1998) Acquired factor V inhibitors. Baillieres Clin Haematol 11:305–318

Franchini M, Lippi G (2011) Acquired factor V inhibitors: a systematic review. J Thromb Thrombolysis 31:449–457

Franchini M, Gandini G, Di Paolantonio T et al (2005) Acquired hemophilia A: a concise review. Am J Hematol 80:55–63

Ang AL, Kuperan P, Ng CH et al (2009) Acquired factor V inhibitor. A problem-based systematic review. Thromb Haemost 101:852–859

Wang X, Qin X, Yu Y, Wang R, et al. (2016) Acquired factor V deficiency in a patient with a urinary tract infection presenting with haematuria followed by multiple haemorrhages with an extremely low level of factor V inhibitor: a case report and review of the literature. Blood Coagul Fibrinolysis (in press) doi: 10.1097/MBC.0000000000000581